Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 10/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27244719 | 1.00 | BACE1 (0.47) | BACE1OPRM1OPRK1OPRL1KMT2A | |
| SCHEMBL30890621 | 0.84 | BACE1 (0.69) | BACE1OPRM1OPRK1OPRL1KMT2A | |
| SCHEMBL27245228 | 0.84 | BACE1 (0.69) | BACE1OPRM1OPRK1OPRL1KMT2A | |
| SCHEMBL24403333 | 0.80 | BACE1 (0.70) | BACE1OPRM1OPRK1OPRL1KMT2A | |
| SCHEMBL30536706 | 0.80 | BACE1 (0.70) | BACE1OPRM1OPRK1OPRL1KMT2A | |
| SCHEMBL24459149 | 0.80 | BACE1 (0.70) | BACE1OPRM1OPRK1OPRL1KMT2A | |
| SCHEMBL26312575 | 0.80 | BACE1 (0.70) | BACE1OPRM1OPRK1OPRL1KMT2A | |
| SCHEMBL30798920 | 0.80 | BACE1 (0.56) | BACE1OPRM1OPRK1OPRL1KMT2A | |
| SCHEMBL24453861 | 0.79 | BACE1 (0.69) | BACE1OPRM1OPRK1OPRL1HTR2A | |
| Hydrochloric Acid SCHEMBL30536654 | 0.79 | BACE1 (0.69) | BACE1OPRM1OPRK1OPRL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612156-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |